Response to: Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker Syndrome?
https://doi.org/10.4081/vl.2023.12137
Accepted: 2 December 2023
HTML: 0
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Not available.
Siniscalchi EN, Raffa G. Is there any clinical reason to administer anticoagulant therapy to patients with the Jugular Vein Nutcracker syndrome? Veins and Lymphatics. 2023;12:12088. DOI: https://doi.org/10.4081/vl.2023.12088
Angelini C, Mantovani G, Cavallo MA, Scerrati A, Bonis PD. Neurosurgical implications of the Jugular Vein Nutcracker. Veins and Lymphatics. 2023;12:11892. DOI: https://doi.org/10.4081/vl.2023.11892
Bai C, Wang Z, Guan J, et al. Clinical characteristics and neuroimaging findings in eagle syndrome induced internal jugular vein stenosis. Ann Transl Med. 2020;8:97. DOI: https://doi.org/10.21037/atm.2019.12.93
Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013;11:71-80. DOI: https://doi.org/10.1111/jth.12071
Scerrati A, Menegatti E, Zamboni M, et al. Internal Jugular Vein Thrombosis: Etiology, Symptomatology, Diagnosis and Current Treatment. Diagnostics. 2021;11:378. DOI: https://doi.org/10.3390/diagnostics11020378
ten Cate V, Rapp S, Schulz A, et al. Circulating microRNAs predict recurrence and death following venous thromboembolism. Journal of Thrombosis and Haemostasis. 2023;21:2797-810. DOI: https://doi.org/10.1016/j.jtha.2023.07.010
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
